Sotylize Approval History
- FDA approved: Yes (First approved October 22nd, 2014)
- Brand name: Sotylize
- Generic name: sotalol hydrochloride
- Dosage form: Oral Solution
- Company: Arbor Pharmaceuticals, LLC
- Treatment for: Ventricular Arrhythmia, Atrial Fibrillation, Atrial Flutter
Sotylize (sotalol hydrochloride) is an antiarrhythmic indicated for the treatment of ventricular arrhythmias and the maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation/flutter.
Development History and FDA Approval Process for Sotylize
|Oct 23, 2014||Arbor Pharmaceuticals Announces FDA Approval of Sotylize|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.